Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.9%

86 terminated/withdrawn out of 1465 trials

Success Rate

90.5%

+4.0% vs industry average

Late-Stage Pipeline

15%

221 trials in Phase 3/4

Results Transparency

10%

85 of 822 completed trials have results

Key Signals

236 recruiting85 with results71 terminated15 withdrawn

Enrollment Performance

Analytics

N/A

792(66.6%)

Phase 3

141(11.8%)

Phase 2

125(10.5%)

Phase 4

80(6.7%)

Phase 1

47(3.9%)

Early Phase 1

5(0.4%)

1190Total

N/A(792)

Phase 3(141)

Phase 2(125)

Phase 4(80)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1465)

Showing 20 of 1465 trials

NCT06268626Recruiting

Detection of Endometrial Cancer Through Risk Modelling

Role: collaborator

NCT06439225Phase 3Recruiting

Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

Role: collaborator

NCT07519928Not ApplicableRecruiting

Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for People With Spinal Cord Injury

Role: collaborator

NCT01655615Not ApplicableCompleted

The Co-Venture Trial: A Cluster Randomized Trial of Personality-targeted Interventions on Adolescent Substance Use and Cognitive Outcomes

Role: collaborator

NCT03935750Not ApplicableActive Not Recruiting

STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon

Role: collaborator

NCT06182774Phase 3Recruiting

Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

Role: collaborator

NCT06320236Recruiting

Emergency Medicine Pulmonary Embolism Testing Multicentre Study

Role: collaborator

NCT06641791Phase 3Recruiting

Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer

Role: collaborator

NCT07300579Not Yet Recruiting

Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2

Role: collaborator

NCT05364749Recruiting

Selective CT for Anticoagulated Head Injured Patients

Role: collaborator

NCT03043417Not ApplicableCompleted

Stigma Intervention Among Primary Health Workers in Toronto

Role: collaborator

NCT07297667Phase 1Not Yet Recruiting

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Role: collaborator

NCT01324648Not ApplicableTerminated

Evaluation of the Bounce Back Program

Role: collaborator

NCT05651282Phase 4Completed

Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer

Role: collaborator

NCT03988933Phase 2Completed

2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.

Role: collaborator

NCT05061368Phase 2Recruiting

Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD

Role: collaborator

NCT01545999Not ApplicableActive Not Recruiting

Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia

Role: collaborator

NCT07518641Not ApplicableNot Yet Recruiting

Feasibility of the TransitionED Framework for Youth and Young Adults With Eating Disorders

Role: collaborator

NCT06878417Not ApplicableRecruiting

Cannabinoids for Osteoarthritis Pain Effectiveness Trial

Role: collaborator

NCT04704037Not ApplicableCompleted

Mobilizing Early Management of Mental Health Complications After Mild Traumatic Brain Injury

Role: collaborator